Article
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype.
The European respiratory journal - 1 Mar 2014
Warth Arne, Penzel Roland, Lindenmaier Heike, Brandt Regine, Stenzinger Albrecht, Herpel Esther, Goeppert Benjamin, Thomas Michael, Herth Felix J F, Dienemann Hendrik, Schnabel Philipp A, Schirmacher Peter, Hoffmann Hans, Muley Thomas, Weichert Wilko
Abstract excerpt
Numerous studies have been published on single aspects of pulmonary adenocarcinoma (ADC). To comprehensively link clinically relevant ADC characteristics, we evaluated established morphological, diagnostic and predictive biomarkers in 425 resected ADCs. Morphology was reclassified. Cytokeratin-7, thyroid transcription factor (TTF)1, napsin A, thymidylate synthase and excision repair cross-complementing rodent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
